Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis (Q36745067)

16 August 2017

1 reference

title

Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis (English)

1 reference

16 August 2017

1 reference

Andrew P Lane

1 reference

16 August 2017

author name string

Murugappan Ramanathan

series ordinal

1 reference

16 August 2017

language of work or name

1 reference

1 March 2007

1 reference

Otolaryngology—Head and Neck Surgery

16 August 2017

published in

1 reference

16 August 2017

volume

136

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

348-356

1 reference

First-line management of sinusitis: a national problem? Overview

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Rhinosinusitis: Establishing definitions for clinical research and patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

The role of the eosinophil in nasal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Interleukin-13 in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

The role of IL-13 and its receptor in allergy and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Mucus clearance as a primary innate defense mechanism for mammalian airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Killing of gram-negative bacteria by lactoferrin and lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Defensins: antimicrobial and cytotoxic peptides of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Human beta-defensins and toll-like receptors in the upper airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Activation of airway epithelial cells by toll-like receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Role of Toll-like receptors in pathogen recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Toll-like receptors: function and roles in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Identification of a novel acidic mammalian chitinase distinct from chitotriosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Increased expression of acidic mammalian chitinase in chronic rhinosinusitis with nasal polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Production of beta-defensin antimicrobial peptides by maxillary sinus mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Presence of surfactant lamellar bodies in normal and diseased sinus mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Innate immunity: impact on the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Toll-like receptor 4 or 2 agonists decrease allergic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Group II Phospholipase A2in Nasal Fluid, Mucosa and Paranasal Sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

Expression of Human ß-defensin 1 mRNA in Human Nasal Mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.011

10.1016/J.OTOHNS.2006.11.011

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference